These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23472214)

  • 21. [Th1 immune response induced by Mycobacterium tuberculosis H37Ra in NOD2 knockout mice].
    Chen S; Zhang Q; Liu J; Tang Y; Han H; Liang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):577-582. PubMed ID: 31537240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis produces D-serine under hypoxia to limit CD8
    Cheng H; Ji Z; Wang Y; Li S; Tang T; Wang F; Peng C; Wu X; Cheng Y; Liu Z; Ma M; Wang J; Huang X; Wang L; Qin L; Liu H; Chen J; Zheng R; Feng CG; Cai X; Qu D; Ye L; Yang H; Ge B
    Nat Microbiol; 2024 Jul; 9(7):1856-1872. PubMed ID: 38806671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.
    Day CL; Mkhwanazi N; Reddy S; Mncube Z; van der Stok M; Klenerman P; Walker BD
    J Infect Dis; 2008 Apr; 197(7):990-9. PubMed ID: 18419535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis.
    Feng CG; Bean AG; Hooi H; Briscoe H; Britton WJ
    Infect Immun; 1999 Jul; 67(7):3242-7. PubMed ID: 10377097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.
    Caccamo N; Guggino G; Meraviglia S; Gelsomino G; Di Carlo P; Titone L; Bocchino M; Galati D; Matarese A; Nouta J; Klein MR; Salerno A; Sanduzzi A; Dieli F; Ottenhoff TH
    PLoS One; 2009; 4(5):e5528. PubMed ID: 19436760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection.
    Ma Y; Chen HD; Wang Y; Wang Q; Li Y; Zhao Y; Zhang XL
    Microbes Infect; 2011 Nov; 13(12-13):1099-110. PubMed ID: 21787878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4-CD8-αβ and γδ T cells display inflammatory and regulatory potentials during human tuberculosis.
    Pinheiro MB; Antonelli LR; Sathler-Avelar R; Vitelli-Avelar DM; Spindola-de-Miranda S; Guimarães TM; Teixeira-Carvalho A; Martins-Filho OA; Toledo VP
    PLoS One; 2012; 7(12):e50923. PubMed ID: 23239994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels.
    Ranjbar S; Ly N; Thim S; Reynes JM; Goldfeld AE
    J Immunol; 2004 Feb; 172(3):1953-9. PubMed ID: 14734781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis.
    Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN
    BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis.
    Caccamo N; Sireci G; Meraviglia S; Dieli F; Ivanyi J; Salerno A
    Eur J Immunol; 2006 Oct; 36(10):2681-90. PubMed ID: 16981183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.
    Sia JK; Bizzell E; Madan-Lala R; Rengarajan J
    PLoS Pathog; 2017 Aug; 13(8):e1006530. PubMed ID: 28767735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.
    Carranza C; Juárez E; Torres M; Ellner JJ; Sada E; Schwander SK
    Am J Respir Crit Care Med; 2006 Jan; 173(2):238-45. PubMed ID: 16210664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.
    Sada-Ovalle I; Chiba A; Gonzales A; Brenner MB; Behar SM
    PLoS Pathog; 2008 Dec; 4(12):e1000239. PubMed ID: 19079582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8
    Suarez GV; Melucci Ganzarain CDC; Vecchione MB; Trifone CA; Marín Franco JL; Genoula M; Moraña EJ; Balboa L; Quiroga MF
    Sci Rep; 2019 Jan; 9(1):187. PubMed ID: 30655556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection.
    Nouailles G; Day TA; Kuhlmann S; Loewe D; Dorhoi A; Gamradt P; Hurwitz R; Jörg S; Pradl L; Hutloff A; Koch M; Kursar M; Kaufmann SH
    Eur J Immunol; 2011 Apr; 41(4):981-91. PubMed ID: 21337542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
    Tully G; Kortsik C; Höhn H; Zehbe I; Hitzler WE; Neukirch C; Freitag K; Kayser K; Maeurer MJ
    J Immunol; 2005 Feb; 174(4):2174-84. PubMed ID: 15699149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.
    Fremond CM; Yeremeev V; Nicolle DM; Jacobs M; Quesniaux VF; Ryffel B
    J Clin Invest; 2004 Dec; 114(12):1790-9. PubMed ID: 15599404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8
    Prezzemolo T; van Meijgaarden KE; Franken KLMC; Caccamo N; Dieli F; Ottenhoff THM; Joosten SA
    Eur J Immunol; 2018 Feb; 48(2):293-305. PubMed ID: 29124751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.